Nevis Brands（NEVI.F）株式概要ネビス・ブランズ社は米国で大麻製品の開発・販売を行っている。 詳細NEVI.F ファンダメンタル分析スノーフレーク・スコア評価4/6将来の成長0/6過去の実績0/6財務の健全性5/6配当金0/6報酬当社が推定した公正価値より87.1%で取引されている 過去5年間の収益は年間31%増加しました。 リスク分析意味のある時価総額がありません ( $841K )株式の流動性は非常に低い 意味のある収益がありません ( CA$2M )すべてのリスクチェックを見るNEVI.F Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$0.02196.0% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-3m23m2016201920222025202620282031Revenue CA$23.4mEarnings CA$2.3mAdvancedSet Fair ValueView all narrativesNevis Brands Inc. 競合他社Functional BrandsSymbol: NasdaqCM:MEHAMarket cap: US$1.5mTradewinds UniversalSymbol: OTCPK:TRWDMarket cap: US$2.8mParanovus Entertainment TechnologySymbol: NasdaqCM:PAVSMarket cap: US$1.2mDSwissSymbol: OTCPK:DQWSMarket cap: US$8.8m価格と性能株価の高値、安値、推移の概要Nevis Brands過去の株価現在の株価US$0.02152週高値US$0.0852週安値US$0.021ベータ0.831ヶ月の変化-15.20%3ヶ月変化n/a1年変化-47.00%3年間の変化n/a5年間の変化-95.47%IPOからの変化-97.65%最新ニュースお知らせ • Jun 30Nevis Brands Inc., Annual General Meeting, Aug 27, 2025Nevis Brands Inc., Annual General Meeting, Aug 27, 2025. Location: british columbia, vancouver Canadaお知らせ • Feb 21Nevis Brands Inc. announced that it expects to receive $0.1 million in fundingNevis Brands Inc. announced that it will issue an unsecured promissory note with returning investor, John Kueber for principal amount of $100,000 on February 20, 2025. The Kueber Note carry a coupon of 10% per annum and will mature on February 15, 2026. The transaction has been approved by the shareholder board.お知らせ • Oct 27Nevis Brands Inc. announced that it expects to receive $0.225 million in fundingNevis Brands Inc. announced a non-brokered private placement of up to 2,500,000 common shares at a price of $0.09 per share for aggregate gross proceeds of up to $225,000 on October 25, 2024. The transaction will include participation from certain insiders of the company. All securities issued in connection with the offering will be subject to a statutory hold period of four months and one day from the date of issuance.お知らせ • Jul 04Nevis Brands Inc., Annual General Meeting, Aug 29, 2024Nevis Brands Inc., Annual General Meeting, Aug 29, 2024. Location: british columbia, vancouver Canadaお知らせ • May 10Nevis Brands Inc Receives Necessary State Regulatory Approvals and Is Completing Production on 3 New Products to Add to Its Existing Portfolio of Products for Sale in Washington StateNevis Brands Inc. announced it has received necessary state regulatory approvals and is completing production on 3 new products to add to its existing portfolio of products for sale in Washington State. These include Major(TM) Apple Peach 100mg Shots Major(TM) Zero Cal Lemonade 100mg Shots Happy Apple (TM) 10mg Cans. These new products will be in market in May 2024 and are expected to contribute to the company's royalty revenues beginning June 2024. Washington State dispensaries currently sell over $700,000 per month of Nevis related products through licensed dispensaries. Products include Major(TM) in 9 flavors, Happy Apple(TM) 100mg bottles, Vertus(TM) a sparkling cider designed to emulate Prosecco, and Velvet Swing(TM). Nevis collects royalties on the sale of these products through its exclusive licensee in each market. The Company may also introduce these new products to licensees in other states. Nevis Brands products are currently sold in Washington, Oregon, Arizona, Ohio, Colorado, California, Missouri and Nevada. The Company is preparing for production in Michigan.お知らせ • Dec 19Nevis Brands Inc. Announces Product Extension in OhioNevis Brands Inc. announced several corporate updates: Product Extension in Ohio: The Company has expanded its Major line of beverages to include a 6th flavor of Major: Atomic Apple. Production has now been completed and inventory is being sold to Ohio retailers. Product Expansion: Washington State. The Company has filed 3 new products for approval in Washington State. The products include two new beverage products and an additional edible product. Nevis will announce specifics of the products upon approval and when production has started.最新情報をもっと見るRecent updatesお知らせ • Jun 30Nevis Brands Inc., Annual General Meeting, Aug 27, 2025Nevis Brands Inc., Annual General Meeting, Aug 27, 2025. Location: british columbia, vancouver Canadaお知らせ • Feb 21Nevis Brands Inc. announced that it expects to receive $0.1 million in fundingNevis Brands Inc. announced that it will issue an unsecured promissory note with returning investor, John Kueber for principal amount of $100,000 on February 20, 2025. The Kueber Note carry a coupon of 10% per annum and will mature on February 15, 2026. The transaction has been approved by the shareholder board.お知らせ • Oct 27Nevis Brands Inc. announced that it expects to receive $0.225 million in fundingNevis Brands Inc. announced a non-brokered private placement of up to 2,500,000 common shares at a price of $0.09 per share for aggregate gross proceeds of up to $225,000 on October 25, 2024. The transaction will include participation from certain insiders of the company. All securities issued in connection with the offering will be subject to a statutory hold period of four months and one day from the date of issuance.お知らせ • Jul 04Nevis Brands Inc., Annual General Meeting, Aug 29, 2024Nevis Brands Inc., Annual General Meeting, Aug 29, 2024. Location: british columbia, vancouver Canadaお知らせ • May 10Nevis Brands Inc Receives Necessary State Regulatory Approvals and Is Completing Production on 3 New Products to Add to Its Existing Portfolio of Products for Sale in Washington StateNevis Brands Inc. announced it has received necessary state regulatory approvals and is completing production on 3 new products to add to its existing portfolio of products for sale in Washington State. These include Major(TM) Apple Peach 100mg Shots Major(TM) Zero Cal Lemonade 100mg Shots Happy Apple (TM) 10mg Cans. These new products will be in market in May 2024 and are expected to contribute to the company's royalty revenues beginning June 2024. Washington State dispensaries currently sell over $700,000 per month of Nevis related products through licensed dispensaries. Products include Major(TM) in 9 flavors, Happy Apple(TM) 100mg bottles, Vertus(TM) a sparkling cider designed to emulate Prosecco, and Velvet Swing(TM). Nevis collects royalties on the sale of these products through its exclusive licensee in each market. The Company may also introduce these new products to licensees in other states. Nevis Brands products are currently sold in Washington, Oregon, Arizona, Ohio, Colorado, California, Missouri and Nevada. The Company is preparing for production in Michigan.お知らせ • Dec 19Nevis Brands Inc. Announces Product Extension in OhioNevis Brands Inc. announced several corporate updates: Product Extension in Ohio: The Company has expanded its Major line of beverages to include a 6th flavor of Major: Atomic Apple. Production has now been completed and inventory is being sold to Ohio retailers. Product Expansion: Washington State. The Company has filed 3 new products for approval in Washington State. The products include two new beverage products and an additional edible product. Nevis will announce specifics of the products upon approval and when production has started.お知らせ • Jul 07Nevis Brands Inc. announced that it has received CAD 2 million in fundingOn July 6, 2023, Nevis Brands Inc. closed the transaction. The company issued 4,805,000 common shares at an issue price of CAD 0.10 per share for gross proceeds of CAD 480,500 in its second and final tranche closing. The company issued 2,402,500 share purchase warrants exercisable for one year at a price of CAD 0.20 per share. A finder’s fee of CAD 32,235 was paid and the finder was issued 230,250 warrants on the same terms as the private placement warrants. All shares have a hold period expiring November 7, 2023.お知らせ • Jun 17Pascal Biosciences Inc., Annual General Meeting, Jul 25, 2023Pascal Biosciences Inc., Annual General Meeting, Jul 25, 2023. Location: Vancouver, BC Vancouver Canadaお知らせ • Jun 15+ 1 more updateNevis Brands Inc. Announces CEO ChangesNevis Brands Inc. announced that Patrick Gray resigned as the CEO of the Company and John Kueber was appointed as CEO.お知らせ • May 19Pascal Biosciences Inc.'s Shares Will Be De-Listed from the TSX.V At the Close of the Market on May 23, 2023Shareholders of Pascal Biosciences Inc. owning 56% of the issued shares of the company have approved the reorganization of the company, including delisting from the TSX Venture Exchange. Details of the reorganization were disclosed in prior releases dated Dec. 9, 2022, and Feb. 15, 2023. At the request of the Company, the Shares will be de-listed from the TSX.V at the close of the market on May 23, 2023. Immediately thereafter: (i) the Company's name will be changed to Nevis Brands Inc., (ii) the Shares will consolidate on the basis of one new share for five old shares, and (iii) the Company's board of directors and the CEO will change. A news release will be issued the next day providing details about the new directors and the CEO. The Company has received a conditional listing letter dated April 26, 2023 from the Canadian Securities Exchange (the "CSE"). That letter requires the Company's reorganization to complete on the day the Shares are listed on the CSE (the "Listing Date"). On the Listing Date, a private placement of $2,000,000 (the "Private Placement") and the acquisition of THC Essentials (the Acquisition") are required to close as well as issuing Shares for debt, which will complete the reorganization. Completion of the transactions disclosed in this press release are subject to a number of conditions, including closing the Private Placement and the Acquisition. There can be no assurance that the Transaction will be completed as proposed or at all. Investors are cautioned that, except as disclosed in further news releases or the CSE form 2AListing Statement, still to be finalized, any information released or received with respect to the transactions may not be accurate or complete and should not be relied upon. The Shares of the Company have been halted since the first week of December 2022.株主還元NEVI.FUS Personal ProductsUS 市場7D-14.1%-2.1%-0.3%1Y-47.0%-20.0%26.7%株主還元を見る業界別リターン: NEVI.F過去 1 年間で-20 % の収益を上げたUS Personal Products業界を下回りました。リターン対市場: NEVI.Fは、過去 1 年間で26.7 % のリターンを上げたUS市場を下回りました。価格変動Is NEVI.F's price volatile compared to industry and market?NEVI.F volatilityNEVI.F Average Weekly Movementn/aPersonal Products Industry Average Movement7.8%Market Average Movement7.2%10% most volatile stocks in US Market16.2%10% least volatile stocks in US Market3.2%安定した株価: NEVI.Fの株価は、 US市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間のNEVI.Fのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイトn/a2John Kueberwww.nevisbrands.comNevis Brands Inc.は米国で大麻製品の開発・販売を行っている。同社は麻由来のTHC飲料をMajorのブランド名で提供している。以前はパスカル・バイオサイエンシズ社として知られていたが、2023年6月にネビス・ブランズ社に社名変更。本社はワシントン州シアトル。もっと見るNevis Brands Inc. 基礎のまとめNevis Brands の収益と売上を時価総額と比較するとどうか。NEVI.F 基礎統計学時価総額US$840.85k収益（TTM）-US$200.15k売上高(TTM)US$1.23m0.7xP/Sレシオ-4.2xPER（株価収益率NEVI.F は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計NEVI.F 損益計算書（TTM）収益CA$1.70m売上原価CA$657.81k売上総利益CA$1.04mその他の費用CA$1.31m収益-CA$275.07k直近の収益報告Nov 30, 2025次回決算日該当なし一株当たり利益（EPS）-0.0069グロス・マージン61.21%純利益率-16.22%有利子負債／自己資本比率47.8%NEVI.F の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/21 06:10終値2026/05/19 00:00収益2025/11/30年間収益2025/11/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Nevis Brands Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jun 30Nevis Brands Inc., Annual General Meeting, Aug 27, 2025Nevis Brands Inc., Annual General Meeting, Aug 27, 2025. Location: british columbia, vancouver Canada
お知らせ • Feb 21Nevis Brands Inc. announced that it expects to receive $0.1 million in fundingNevis Brands Inc. announced that it will issue an unsecured promissory note with returning investor, John Kueber for principal amount of $100,000 on February 20, 2025. The Kueber Note carry a coupon of 10% per annum and will mature on February 15, 2026. The transaction has been approved by the shareholder board.
お知らせ • Oct 27Nevis Brands Inc. announced that it expects to receive $0.225 million in fundingNevis Brands Inc. announced a non-brokered private placement of up to 2,500,000 common shares at a price of $0.09 per share for aggregate gross proceeds of up to $225,000 on October 25, 2024. The transaction will include participation from certain insiders of the company. All securities issued in connection with the offering will be subject to a statutory hold period of four months and one day from the date of issuance.
お知らせ • Jul 04Nevis Brands Inc., Annual General Meeting, Aug 29, 2024Nevis Brands Inc., Annual General Meeting, Aug 29, 2024. Location: british columbia, vancouver Canada
お知らせ • May 10Nevis Brands Inc Receives Necessary State Regulatory Approvals and Is Completing Production on 3 New Products to Add to Its Existing Portfolio of Products for Sale in Washington StateNevis Brands Inc. announced it has received necessary state regulatory approvals and is completing production on 3 new products to add to its existing portfolio of products for sale in Washington State. These include Major(TM) Apple Peach 100mg Shots Major(TM) Zero Cal Lemonade 100mg Shots Happy Apple (TM) 10mg Cans. These new products will be in market in May 2024 and are expected to contribute to the company's royalty revenues beginning June 2024. Washington State dispensaries currently sell over $700,000 per month of Nevis related products through licensed dispensaries. Products include Major(TM) in 9 flavors, Happy Apple(TM) 100mg bottles, Vertus(TM) a sparkling cider designed to emulate Prosecco, and Velvet Swing(TM). Nevis collects royalties on the sale of these products through its exclusive licensee in each market. The Company may also introduce these new products to licensees in other states. Nevis Brands products are currently sold in Washington, Oregon, Arizona, Ohio, Colorado, California, Missouri and Nevada. The Company is preparing for production in Michigan.
お知らせ • Dec 19Nevis Brands Inc. Announces Product Extension in OhioNevis Brands Inc. announced several corporate updates: Product Extension in Ohio: The Company has expanded its Major line of beverages to include a 6th flavor of Major: Atomic Apple. Production has now been completed and inventory is being sold to Ohio retailers. Product Expansion: Washington State. The Company has filed 3 new products for approval in Washington State. The products include two new beverage products and an additional edible product. Nevis will announce specifics of the products upon approval and when production has started.
お知らせ • Jun 30Nevis Brands Inc., Annual General Meeting, Aug 27, 2025Nevis Brands Inc., Annual General Meeting, Aug 27, 2025. Location: british columbia, vancouver Canada
お知らせ • Feb 21Nevis Brands Inc. announced that it expects to receive $0.1 million in fundingNevis Brands Inc. announced that it will issue an unsecured promissory note with returning investor, John Kueber for principal amount of $100,000 on February 20, 2025. The Kueber Note carry a coupon of 10% per annum and will mature on February 15, 2026. The transaction has been approved by the shareholder board.
お知らせ • Oct 27Nevis Brands Inc. announced that it expects to receive $0.225 million in fundingNevis Brands Inc. announced a non-brokered private placement of up to 2,500,000 common shares at a price of $0.09 per share for aggregate gross proceeds of up to $225,000 on October 25, 2024. The transaction will include participation from certain insiders of the company. All securities issued in connection with the offering will be subject to a statutory hold period of four months and one day from the date of issuance.
お知らせ • Jul 04Nevis Brands Inc., Annual General Meeting, Aug 29, 2024Nevis Brands Inc., Annual General Meeting, Aug 29, 2024. Location: british columbia, vancouver Canada
お知らせ • May 10Nevis Brands Inc Receives Necessary State Regulatory Approvals and Is Completing Production on 3 New Products to Add to Its Existing Portfolio of Products for Sale in Washington StateNevis Brands Inc. announced it has received necessary state regulatory approvals and is completing production on 3 new products to add to its existing portfolio of products for sale in Washington State. These include Major(TM) Apple Peach 100mg Shots Major(TM) Zero Cal Lemonade 100mg Shots Happy Apple (TM) 10mg Cans. These new products will be in market in May 2024 and are expected to contribute to the company's royalty revenues beginning June 2024. Washington State dispensaries currently sell over $700,000 per month of Nevis related products through licensed dispensaries. Products include Major(TM) in 9 flavors, Happy Apple(TM) 100mg bottles, Vertus(TM) a sparkling cider designed to emulate Prosecco, and Velvet Swing(TM). Nevis collects royalties on the sale of these products through its exclusive licensee in each market. The Company may also introduce these new products to licensees in other states. Nevis Brands products are currently sold in Washington, Oregon, Arizona, Ohio, Colorado, California, Missouri and Nevada. The Company is preparing for production in Michigan.
お知らせ • Dec 19Nevis Brands Inc. Announces Product Extension in OhioNevis Brands Inc. announced several corporate updates: Product Extension in Ohio: The Company has expanded its Major line of beverages to include a 6th flavor of Major: Atomic Apple. Production has now been completed and inventory is being sold to Ohio retailers. Product Expansion: Washington State. The Company has filed 3 new products for approval in Washington State. The products include two new beverage products and an additional edible product. Nevis will announce specifics of the products upon approval and when production has started.
お知らせ • Jul 07Nevis Brands Inc. announced that it has received CAD 2 million in fundingOn July 6, 2023, Nevis Brands Inc. closed the transaction. The company issued 4,805,000 common shares at an issue price of CAD 0.10 per share for gross proceeds of CAD 480,500 in its second and final tranche closing. The company issued 2,402,500 share purchase warrants exercisable for one year at a price of CAD 0.20 per share. A finder’s fee of CAD 32,235 was paid and the finder was issued 230,250 warrants on the same terms as the private placement warrants. All shares have a hold period expiring November 7, 2023.
お知らせ • Jun 17Pascal Biosciences Inc., Annual General Meeting, Jul 25, 2023Pascal Biosciences Inc., Annual General Meeting, Jul 25, 2023. Location: Vancouver, BC Vancouver Canada
お知らせ • Jun 15+ 1 more updateNevis Brands Inc. Announces CEO ChangesNevis Brands Inc. announced that Patrick Gray resigned as the CEO of the Company and John Kueber was appointed as CEO.
お知らせ • May 19Pascal Biosciences Inc.'s Shares Will Be De-Listed from the TSX.V At the Close of the Market on May 23, 2023Shareholders of Pascal Biosciences Inc. owning 56% of the issued shares of the company have approved the reorganization of the company, including delisting from the TSX Venture Exchange. Details of the reorganization were disclosed in prior releases dated Dec. 9, 2022, and Feb. 15, 2023. At the request of the Company, the Shares will be de-listed from the TSX.V at the close of the market on May 23, 2023. Immediately thereafter: (i) the Company's name will be changed to Nevis Brands Inc., (ii) the Shares will consolidate on the basis of one new share for five old shares, and (iii) the Company's board of directors and the CEO will change. A news release will be issued the next day providing details about the new directors and the CEO. The Company has received a conditional listing letter dated April 26, 2023 from the Canadian Securities Exchange (the "CSE"). That letter requires the Company's reorganization to complete on the day the Shares are listed on the CSE (the "Listing Date"). On the Listing Date, a private placement of $2,000,000 (the "Private Placement") and the acquisition of THC Essentials (the Acquisition") are required to close as well as issuing Shares for debt, which will complete the reorganization. Completion of the transactions disclosed in this press release are subject to a number of conditions, including closing the Private Placement and the Acquisition. There can be no assurance that the Transaction will be completed as proposed or at all. Investors are cautioned that, except as disclosed in further news releases or the CSE form 2AListing Statement, still to be finalized, any information released or received with respect to the transactions may not be accurate or complete and should not be relied upon. The Shares of the Company have been halted since the first week of December 2022.
